Table 2.
Overview of treatment and tumor characteristics for the up-front transoral robotic surgery group (N = 56).
Characteristic | Value (N = 56) | % |
---|---|---|
Subsite | ||
Oropharynx | 46 | 82.1 |
Base of tongue | 9 | |
Tonsil | 32 | |
Posterior wall | 1 | |
Vallecula | 2 | |
Glossotonsillar sulcus | 1 | |
Retromolar trigone | 1 | |
Supraglottic larynx | 5 | 8.9 |
Epiglottis | 3 | |
Aryepiglottic fold | 1 | |
Unknown | 1 | |
Hypopharynx (pyriform sinus) | 5 | 8.9 |
Clinical tumor classification | ||
cT0 Oropharynx | 1 | 1.8 |
cT1 | 23 | 41.1 |
Oropharynx | 17 | |
Supraglottic larynx | 3 | |
Hypopharynx | 3 | |
cT2 | 27 | 48.2 |
Oropharynx | 24 | |
Supraglottic larynx | 2 | |
Hypopharynx | 1 | |
cT3 | 4 | 7.1 |
Oropharynx | 3 | |
Hypopharynx | 1 | |
cT4a Oropharynx | 1 | 1.8 |
Clinical nodal classification | ||
cN0 | 18 | 32.1 |
cN1 | 13 | 23.2 |
cN2 | 25 | 44.6 |
Neck dissection | ||
Yes | 49 | 87.5 |
Levels I–III | 4 | |
Levels II–III | 1 | |
Levels II–IV | 10 | |
Levels I–IV | 4 | |
Levels II–V | 10 | |
Levels I–V | 20 | |
No | 7 | 12.5 |
Surgical margin status | ||
Clear | 21 | 37.5 |
Close (<5 mm) | 10 | 17.9 |
Positive | 24 | 42.9 |
Second primary in margin | 1 | 1.8 |
Pathological tumor classification | ||
pT1 | 24 | 42.9 |
Oropharynx | 18 | |
Supraglottic larynx | 3 | |
Hypopharynx | 3 | |
pT2 | 27 | 48.2 |
Oropharynx | 25 | |
Supraglottic larynx | 1 | |
Hypopharynx | 1 | |
pT3 | 2 | 3.6 |
Oropharynx | 1 | |
Hypopharynx | 1 | |
pT4 | 2 | 3.6 |
Oropharynx | 1 | |
Hypopharynx | 1 | |
pR2 (macroscopic residual tumor) (oropharynx) | 1 | 1.8 |
Pathological nodal classification | ||
pNx | 7 | 12.5 |
pN0 | 15 | 26.8 |
pN1 | 11 | 19.6 |
pN2a | 7 | 12.5 |
pN2b | 16 | 28.6 |
pN2c | 0 | |
Adjuvant treatment | ||
No adjuvant treatment, follow-up | 13 | 23.2 |
Radiotherapy | 26 | 46.4 |
Chemoradiotherapy | 15 | 26.8 |
Surgery (TLM) + radiotherapy | 1 | 1.8 |
Undetermined (early death) | 1 | 1.8 |
TLM, transoral laser microsurgery.